Delafloxacin Meglumine
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Delafloxacin Meglumine is used to treat bacterial infections, escherichia coli infections, klebsiella infections, pseudomonas infections, bacterial skin diseases and staphylococcal infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 19, 2017. In 2024, Medicare Part D spent $1 million on Delafloxacin Meglumine across 661 claims for 450 beneficiaries.
Delafloxacin Meglumine is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $72.31 to $72.31 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$72.31 – $72.31
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DELAFLOXACIN MEGLUMINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BAXDELA 450 MG TABLET | $72.3117 per EA | — |
BAXDELA 450 MG TABLET | $72.3117 per EA | — |
Frequently Asked Questions
What is Delafloxacin Meglumine used to treat?
Delafloxacin Meglumine is used to treat bacterial infections, escherichia coli infections, klebsiella infections, pseudomonas infections, bacterial skin diseases and staphylococcal infections, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Delafloxacin Meglumine?
In 2024, Medicare Part D spent $1 million on Delafloxacin Meglumine across 661 claims for 450 beneficiaries.
How many Delafloxacin Meglumine products are on the market?
The Delafloxacin Meglumine drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Delafloxacin Meglumine?
NADAC reference prices for Delafloxacin Meglumine range from $72.3117 to $72.3117 per EA.
Which manufacturers make Delafloxacin Meglumine?
1 manufacturer lists Delafloxacin Meglumine in NADAC. Ranked by number of NDCs, the largest are Melinta Therapeutics, LLC (2).